Calendar | For Your Patients | PHA Main Site | Contact Us | About Us | Not a registered user? Sign up here.

Courses Quicksearch

Search Now!

Courses

Management of PH in the ICU

Yon Sung


Reviews

  Sign in to add a review

0 comments
Leave a Comment

Course ID: 2821

CEU Information

Description

The management of critically ill patients with pulmonary hypertension can be particularly challenging as many of the treatments used in the ICU setting can exacerbate PH and right heart failure. In this class, we will review the unique aspects of the physiology of critically ill PH patients, which will then inform our approach to management. Specifically, we will discuss the role of invasive hemodynamic monitoring, the advantages and disadvantages of specific vasoactive medications, and the indications for pulmonary vasodilators in the acute setting.

Course Authors

Yon Sung, M.D.
Stanford Hospital and Clinics 
Stanford, Calif.

Course Reviewer

George J. Vuturo, Ph.D., RPh
CME/CE Director
Chief Compliance Officer
Planning Committee Member
Professional Education Services Group, LLC, Sterling, VA

Content Reviewer

Janice Agazio, Ph.D., CRNP, RN, FAANP, FAAN
Lead Nurse Planner Planning Committee Member Professional Education Services Group, LLC,
Sterling, VA Assistant Dean for Doctoral Programs and Ordinary Professor School
of Nursing the Catholic University of America, Washington, DC

CME Reviewer

Danielle Spencer
CME/CE Project Director
Professional Education Services Group, LLC, Sterling, VA

Intended Audience

This continuing education activity provides continuing education (CE) credits for:

  1. Physicians
  2. Nurses
  3. Pharmacists and Pharmacy Technicians
  4. Respiratory Therapists
  5. Social Workers
  6. Other Related Health Professionals

Learning Objectives

At the conclusion of this activity participants should be able to:

  • Recognize the unique features of PH patients with critical illness.
  • Discuss considerations for the use of invasive hemodynamic monitoring in PH patients in the ICU.
  • Review therapies for the management of acute right ventricular failure in patients with PH.
  • Understand the indications for initiation and/or continuation of pulmonary vasodilators in critical illness.

Release Date

January 1, 2017

Expiration Date

December 31, 2017

Estimated Time to Complete This Activity

30 minutes

Continuing Education Information

This continuing education activity is provided through a joint Providership Agreement between The Pulmonary Hypertension Association (PHA) and Professional Education Services Group (PESG). This activity will provide continuing education for nurses, pharmacists, respiratory therapists, and social workers. All other health care professionals completing this continuing education activity will be issued Certificate of Attendance which may be submitted to accrediting organizations or licensing boards to meet CE requirements.

Accreditation Statement

Physicians

  • This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through a joint providership of Professional Education Services Group and the Pulmonary Hypertension Association. Professional Education Services Group is accredited by the ACCME to provide continuing medical education for physicians. This activity has been approved for a maximum of 0.5 hours of AMA PRA Category 1 Credits™. Physicians should only claim credit to the extent of their participation.

Nurses

  • Professional Education Services Group is an accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This activity provides a maximum of 0.5 contact hours of nurse CE credit.

Pharmacists and Pharmacy Technicians

  • Professional Education Services Group is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE UAN 0829-0000-16-193-L04 (Pharmacists) and 0829-0000-16-193-L04 (Pharmacy Technicians). This activity provides 0.5 contact hours (0.10 CEUs) of continuing education credit. There is no cost for this activity. Your record of completion will be reported directly to the CPE Monitor.

Respiratory Therapists

  • The Continuing Respiratory Education (CRCE) system of the American Association for Respiratory Care (AARC) grants approval for 0.5 hours for this course.

Social Workers

  • This program is approved by the National Association of Social Workers for 0.5 Social Work continuing education contact hour.

Instructions for Earning Credit

This activity is a self-study program. In order to claim CE credit, participants must:

  • View the content, examine any images and/or multimedia features, and review the content presented within all of the links provided. Once the course has been reviewed in its entirety, participants will be directed to the CE processing center athttp://pha.cds.pesgce.com and claim CE credit.
  • Complete a post-test and evaluation online. All evaluation questions must be completed in order to receive a CE credit.
  • Upon successful completion of the post-test and online evaluation form, you can instantly download and/or print your certificate of credit. Your CE records will be stored at http://pha.cds.pesgce.com for later retrieval at your convenience.

CE Inquiries

For all CE related inquiries, please contact Support@PESGCE.com or PHA Online University at (301)-565-3004-x771.

Disclosure Policy

As a provider accredited by the Accreditation Council for Continuing Medical Education (ACCME), it is the policy of Professional Educational Services Group (PESG) to require the disclosure of anyone who is in a position to control the content of an educational activity. All relevant financial relationships with any commercial interests and/or manufacturers must be disclosed to participants at the beginning of each activity. The faculty and planners of this educational activity disclose the following:

  • Yon Sung, M.D., has no arrangements to disclose.

Disclaimer

The information presented in this activity reflects the views of the faculty only and not necessarily those of the Pulmonary Hypertension Association (PHA), the sponsors or the educational grant providers. All participants should verify the information and data presented before treating patients or utilizing any therapies noted in these materials. No portion of this activity may be reproduced without the expressed written consent of PHA.

Technical Requirements

This course requires an internet browser. For optimum display, please use Mozilla Firefox, Safari or Google Chrome.

Privacy Policy

For information about PHA's privacy policy, visit http://www.PHAssociation.org/PrivacyPolicy.

This activity is made possible through unrestricted educational grants to the PHA Medical Education Fund from Actelion Pharmaceuticals, US; Gilead Sciences, Bayer HealthCare, and United Therapeutics.

©2016 Pulmonary Hypertension Association, 801 Roeder Road, Suite 1000, Silver Spring, MD 21910.